Security key
62818Q203
Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO)
CUSIP: 62818Q203
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.0001 Par Value
- Total 13F shares
- 786,143
- Total 13F value
- $372,645
- Share change
- +42,535
- SEC-reported price per share
- $0.47
- Number of holders
- 27
- Value change
- -$150,757
- Number of buys
- 16
- Number of sells
- 17
- Shares outstanding
- 52,979,435
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
27
Top holders
10
MBIO full security history
Ownership snapshot
Full 13F holder table
MUSTANG BIO, INC. SEC filings
MUSTANG BIO, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $218,400
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $218.4K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$218.4K
VANGUARD GROUP INC
$213.9K
BlackRock Finance, Inc.
$103.1K
Brian Achenbach
$74.7K
GEODE CAPITAL MANAGEMENT, LLC
$50.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$218,400
210,000 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$213,916
205,688 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$103,067
99,103 shares
|
— | 31 Mar 2024 |
| Brian Achenbach |
3/4/5
SVP, Fin. & Corp. Controller
|
—
denominator unverified
|
$74,738
144,729 shares
|
— | 08 Dec 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$50,345
48,397 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$37,000
35,390 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
786,143
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
28
Q2 2024 holders
27
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|